The 2nd Process Development for Cell Therapies Summit takes place at a pivotal time in cell therapy development. The industry is on the precipice of commercial boom, with an unprecedented number of candidates poised for clinical development. There has never been a more important time to share insights learned so far, and create consensus through discussing pitfalls and triumphs in process development so far.
Join Fellow Process Development Innovators to:
Innovate analytical methods and ditigal platforms to ensure product quality and efficacy with Immatics Biotechnologes and Lyell Immunopharma
Convene on regulations and frameworks for best practices to establish industry standards with CytoImmune Therapeutics and Affini-T Therapeutics
Examine disruptive technologies to plug gaps in process workflows from digital systems to closed-system automation with Takeda and Triumvira Immunologics
Advance allogeneic and iPSC process development, define batches, and contrast sources for scalable ‘off-the-shelf’ therapy with Century Therapeutics and Arovella Therapeutics
Optimize formulation, fill & finish and develop cryopreservation protocols to monitor and maintain product quality with Senti Bio and Be Biopharma
Who will you Meet?
What your peers have to say:
“Great content and exposure to the latest progress being made in the field.”
Director- Potency, Analytical, Cell Based Assay, Center Excellence and Biologics Bioprocess, Merck*
“A huge highlight of my year and the key connections I made will allow for fruitful collaborations and sharing of ideas that will be valuable for years to come.”
Biomedical Engineer, National Institute of Standards & Technology, NIST*
*From similar Cell Therapy Events